Talpin A, Maia A, Carpier J, Kulakowski G, Aubergeon L, Kervevan J
J Immunother Cancer. 2025; 13(2).
PMID: 39979071
PMC: 11842988.
DOI: 10.1136/jitc-2024-010192.
Buckner J
Nat Rev Rheumatol. 2024; 21(2):88-97.
PMID: 39681709
DOI: 10.1038/s41584-024-01201-w.
Pan Y, Bartolo L, Xu R, Patel B, Zarnitsyna V, Su L
JCI Insight. 2024; 9(14).
PMID: 38861490
PMC: 11383171.
DOI: 10.1172/jci.insight.180667.
Jiang N, Malone M, Chizari S
Immunol Rev. 2023; 316(1):120-135.
PMID: 37209375
PMC: 10524458.
DOI: 10.1111/imr.13217.
Dominguez-Horta M, Serrano-Diaz A, Hernandez-Cedeno M, Martinez-Donato G, Guillen-Nieto G
Front Immunol. 2023; 14:1162739.
PMID: 37187739
PMC: 10179499.
DOI: 10.3389/fimmu.2023.1162739.
Adaptive discrimination between harmful and harmless antigens in the immune system by predictive coding.
Yoshido K, Naoki H
iScience. 2023; 26(1):105754.
PMID: 36594030
PMC: 9804113.
DOI: 10.1016/j.isci.2022.105754.
CD8 T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor.
Prokhnevska N, Cardenas M, Valanparambil R, Sobierajska E, Barwick B, Jansen C
Immunity. 2022; 56(1):107-124.e5.
PMID: 36580918
PMC: 10266440.
DOI: 10.1016/j.immuni.2022.12.002.
TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion.
Shakiba M, Zumbo P, Espinosa-Carrasco G, Menocal L, Dundar F, Carson S
J Exp Med. 2021; 219(2).
PMID: 34935874
PMC: 8704919.
DOI: 10.1084/jem.20201966.
mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
Neidleman J, Luo X, McGregor M, Xie G, Murray V, Greene W
Elife. 2021; 10.
PMID: 34636722
PMC: 8545397.
DOI: 10.7554/eLife.72619.
PD-1 preferentially inhibits the activation of low-affinity T cells.
Shimizu K, Sugiura D, Okazaki I, Maruhashi T, Takemoto T, Okazaki T
Proc Natl Acad Sci U S A. 2021; 118(35).
PMID: 34433672
PMC: 8536324.
DOI: 10.1073/pnas.2107141118.
Impact of SARS-CoV-2 variants on the total CD4 and CD8 T cell reactivity in infected or vaccinated individuals.
Tarke A, Sidney J, Methot N, Yu E, Zhang Y, Dan J
Cell Rep Med. 2021; 2(7):100355.
PMID: 34230917
PMC: 8249675.
DOI: 10.1016/j.xcrm.2021.100355.
mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
Neidleman J, Luo X, McGregor M, Xie G, Murray V, Greene W
bioRxiv. 2021; .
PMID: 34013277
PMC: 8132283.
DOI: 10.1101/2021.05.12.443888.
HLA-DRB1 genes and the expression dynamics of HLA CIITA determine the susceptibility to T2DM.
Chinniah R, Sevak V, Pandi S, Ravi P, Vijayan M, Kannan A
Immunogenetics. 2021; 73(4):291-305.
PMID: 33754173
DOI: 10.1007/s00251-021-01212-x.
Negligible impact of SARS-CoV-2 variants on CD4 and CD8 T cell reactivity in COVID-19 exposed donors and vaccinees.
Tarke A, Sidney J, Methot N, Zhang Y, Dan J, Goodwin B
bioRxiv. 2021; .
PMID: 33688655
PMC: 7941626.
DOI: 10.1101/2021.02.27.433180.
Discovery of surrogate agonists for visceral fat Treg cells that modulate metabolic indices in vivo.
Fernandes R, Li C, Wang G, Yang X, Savvides C, Glassman C
Elife. 2020; 9.
PMID: 32773038
PMC: 7440915.
DOI: 10.7554/eLife.58463.
Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants.
de Sousa E, Ligeiro D, Lerias J, Zhang C, Agrati C, Osman M
Int J Infect Dis. 2020; 98:454-459.
PMID: 32693089
PMC: 7368421.
DOI: 10.1016/j.ijid.2020.07.016.
A Disquisition on MHC Restriction and T Cell Recognition in Five Acts.
Greenspan N
Viral Immunol. 2020; 33(3):153-159.
PMID: 32286186
PMC: 7185361.
DOI: 10.1089/vim.2019.0182.
T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.
Grifoni A, Voic H, Dhanda S, Kidd C, Brien J, Buus S
J Virol. 2020; 94(10).
PMID: 32132233
PMC: 7199411.
DOI: 10.1128/JVI.00089-20.
Key Amino Acid Substitution for Infection-Enhancing Activity-Free Designer Dengue Vaccines.
Yamanaka A, Konishi E
iScience. 2019; 13:125-137.
PMID: 30826727
PMC: 6402262.
DOI: 10.1016/j.isci.2019.02.012.
Antigen-specific therapeutic approaches for autoimmunity.
Serra P, Santamaria P
Nat Biotechnol. 2019; 37(3):238-251.
PMID: 30804535
DOI: 10.1038/s41587-019-0015-4.